Filtered By:
Therapy: Hormone Replacement Therapy

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 161 results found since Jan 2013.

Moderate Exercise Cuts Women's Stroke Risk, Helps Offset Increase Risk from Hormone Therapy
Source: American Heart Association Related MedlinePlus Pages: Hormone Replacement Therapy, Stroke
Source: MedlinePlus Health News - February 14, 2014 Category: Consumer Health News Source Type: news

Women on HRT ‘face an increased risk of stroke' according to new review
WOMEN taking hormone replacement therapy are not being protected against heart disease and could be at greater risk of a stroke, according to a review of more than 40,000 cases.
Source: Daily Express - Health - March 10, 2015 Category: Consumer Health News Source Type: news

HRT linked to clots – and possibly stroke – study finds
Women on hormone replacement therapy (HRT) pills should be aware that there is a small chance of an increased risk of blood clots and possibly stroke, according to a study. Hide related content:  Show related content read more
Source: Nursing in Practice - March 13, 2015 Category: Nursing Authors: Kimberley Hackett Tags: Family health Women ' s health Editor s pick Latest News Source Type: news

Worsening migraines in women using HRT indicate increased risk of stroke
Worsening migraines in users of hormone replacement therapy is associated with an increased risk of ischaemic stroke, according to a new study.
Source: The Pharmaceutical Journal - February 25, 2016 Category: Drugs & Pharmacology Source Type: research

Scientists discover a way to banish hot flashes without raising a woman's stroke risk
Scientists at the University of Washington have shown we could target a neuron rather than estrogen levels with drugs. Hormone replacement therapy reduces hot flashes but increases stroke risk.
Source: the Mail online | Health - July 10, 2018 Category: Consumer Health News Source Type: news

Flash of Greater Stroke Risk at Initiation of Oral Contraceptives
(MedPage Today) -- The upfront stroke risk associated with oral contraceptives and hormone replacement therapy (HRT) waned to varying degrees after the first year of use, an observational study found. U.K. Biobank participants on birth control...
Source: MedPage Today Endocrinology - June 24, 2022 Category: Endocrinology Source Type: news

Stroke risk could be higher for women who don't use hormone replacement therapy, study suggests 
Women who go into early menopause or do not use hormone replacement therapy could be at a higher risk of stroke, a study found.
Source: the Mail online | Health - February 2, 2023 Category: Consumer Health News Source Type: news

Migraines linked to increased heart disease risk in women
Conclusion This study shows a strong link between migraine and cardiovascular disease, extending the link already found between migraine and stroke. However, many questions remain. We don't know if the results are relevant to men who have migraines, as all the people in the study were women. We also don't know if the results apply to non-white populations, as most of the women in the study were white. Previous studies on stroke have shown that the group at highest risk is who get an "aura" before a migraine – sensation(s) that tells them the migraine is on its way. But this study did not ask people about aura...
Source: NHS News Feed - June 1, 2016 Category: Consumer Health News Tags: Heart/lungs Neurology Source Type: news

Previous Use of Unopposed Estrogen Hormone Replacement Therapy Continues to Cause Increased Risk for Future Ischemic Strokes (I5.011)
Conclusions:Previous use of unopposed estrogen HRT continues to increase risk for ischemic stroke after they are discontinued, although combination of estrogen and progesterone HRT do no continue to have a significantly increased risk. Future prospective studies are required to further investigate these correlations.Disclosure: Dr. Rahman has nothing to disclose. Dr. Thomas has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Saeed has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Rahman, H., Thomas, A., Malik, A., Saeed, O., Qureshi, A. Tags: Sex-related Factors in Neurological Disease Poster Presentations Source Type: research

Abstract 226: Strokes Worse in Women at 24 hours but Severity Reduced in Younger Women With Hormone Therapy Session Title: Poster Session II
Conclusion: Women in this study had more severe 24 hour AIS outcomes than men but this improved with HRT use in women younger than 80 years. This cannot be fully explained by age differences as there could be other underlying factors. Improving 24 hour NIHSS may correctly predict later outcomes following AIS. Further study of HRT use in AIS outcomes is justified.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Brown, A., Onteddu, S., Joiner, R., Benton, T., Culp, W., Lowery, C. Tags: Session Title: Poster Session II Source Type: research

Transient ischemic attacks in post-menopausal women with history of migraines have lower risk for subsequent ischemic strokes (P2.306)
CONCLUSIONS: The risk of ischemic stroke is lower following TIA in women with migraine history (compared with those without migraine) suggesting potentially different pathophysiology in such women.Disclosure: Dr. Rahman has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Thomas has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Rahman, H., Malik, A., Thomas, A., Qureshi, A. Tags: Cerebrovascular Disease and Interventional Neurology: Education and TIA Source Type: research

Carotid plaque thickness is positively associated with decreased bone mineral density (P2.264)
CONCLUSIONS: This study showed that increased maximum carotid IMT/plaque value is significantly associated with decreased BMD after controlling for the effects of age, gender, and BMI in acute stroke patients. Study Supported by: NoneDisclosure: Dr. Han has nothing to disclose. Dr. Park has nothing to disclose. Dr. Park has nothing to disclose. Dr. Lee has nothing to disclose. Dr. Lee has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Han, S. W., Park, J. H., Park, J. H., Lee, J. Y., Lee, K.-Y. Tags: Cerebrovascular Disease and Interventional Neurology: Carotid Disease and IMT Source Type: research

Beyond contraception and hormone replacement therapy: advancing Nestorone to a neuroprotective drug in the clinic.
Abstract Neurological diseases such as ischemic stroke can be debilitating and have limited treatments available. The progestin Nestorone® (segesterone acetate) has been evaluated for use in birth control and hormone replacement therapy due to its potency and high affinity for the progesterone receptor. Interestingly, Nestorone also exerts neuroprotection in animals afflicted with various central nervous system diseases, including stroke, which implicates its potential for treating these maladies in clinical settings. In fact, a recent Brain Research paper by Tanaka and colleagues demonstrates Nestorone's ability...
Source: Brain Research - October 12, 2018 Category: Neurology Authors: Tuazon JP, Sitruk-Ware R, Borlongan CV Tags: Brain Res Source Type: research

Reprint of: Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic.
Abstract Neurological diseases such as ischemic stroke can be debilitating and have limited treatments available. The progestin Nestorone® (segesterone acetate) has been evaluated for use in birth control and hormone replacement therapy due to its potency and high affinity for the progesterone receptor. Interestingly, Nestorone also exerts neuroprotection in animals afflicted with various central nervous system diseases, including stroke, which implicates its potential for treating these maladies in clinical settings. In fact, a recent Brain Research paper by Tanaka and colleagues demonstrates Nestorone's ability...
Source: Brain Research - June 14, 2019 Category: Neurology Authors: Tuazon JP, Sitruk-Ware R, Borlongan CV Tags: Brain Res Source Type: research

A Post-Hoc Assessment of Current Hormone Therapy on Revascularization Risk in Women: The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (P03.168)
CONCLUSIONS: We found that women on current HRT have lower periprocedural risk associated with CAS or CEA than non-users, but little difference in risk after the procedural period. The mechanism for this unexpected finding is elusive. We urge caution in the interpretation of this post-hoc observation and encourage replication or refutation by other revascularization studies with similar data.Disclosure: Dr. Mackey has nothing to disclose. Dr. Lutsep has received personal compensation for serving on Consultant/Advisory Boards for Concentric Medical/Stryker, Co-Axia, and AGA Medical. Dr. Lutsep has received personal compensa...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Mackey, A., Lutsep, H., Milot, G., Voeks, J., Howard, V., Hughes, S., Tom, M., Longbottom, M., Sheffet, A., Brott, T. Tags: P03 Cerebrovascular Disease III Source Type: research